Patrick B Trotter1, Dominic M Summers, Matthew Robb, William Hulme, Ines Ushiro-Lumb, Christopher J E Watson, James Neuberger, J Andrew Bradley. 1. 1 National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit (BTRU) at the University of Cambridge in collaboration with Newcastle University and in partnership with National Health Service Blood and Transplant (NHSBT), Cambridge, United Kingdom. 2 NHS Blood and Transplant, Fox Den Road, Bristol, United Kingdom. 3 Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Abstract
BACKGROUND: Deceased organ donors are routinely screened for behaviors that increase the risk of transmissible blood-borne viral (BBV) infection, but the impact of this information on organ donation and transplant outcome is not well documented. Our aim was to establish the impact of such behavior on organ donation and utilization, as well transplant recipient outcomes. METHODS: We identified all UK deceased organ donors from 2003 to 2015 with a disclosed history of increased risk behavior (IRB) including intravenous drug use (IVDU), imprisonment and increased risk sexual behavior. RESULTS: Of 17 262 potential donors, 659 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB (mostly IVDU [78.5%]). Of actual donors with IRB, 393 were seronegative for viral markers at time of donation. A history of recent IVDU was associated with fewer potential donors proceeding to become actual organ donors (64% vs 75%, P = 0.007). Donors with IRB provided 1091 organs for transplantation (624 kidneys and 467 other organs). Transplant outcome was similar in recipients of organs from donors with and without IRB. There were 3 cases of unexpected hepatitis C virus transmission, all from an active IVDU donor who was hepatitis C virus seronegative at time of donation, but was found to be viremic on retrospective testing. CONCLUSIONS: Donors with a history of IRB provide a valuable source of organs for transplantation with good transplant outcomes and there is scope for increasing the use of organs from such donors.
BACKGROUND: Deceased organ donors are routinely screened for behaviors that increase the risk of transmissible blood-borne viral (BBV) infection, but the impact of this information on organ donation and transplant outcome is not well documented. Our aim was to establish the impact of such behavior on organ donation and utilization, as well transplant recipient outcomes. METHODS: We identified all UK deceased organ donors from 2003 to 2015 with a disclosed history of increased risk behavior (IRB) including intravenous drug use (IVDU), imprisonment and increased risk sexual behavior. RESULTS: Of 17 262 potential donors, 659 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB (mostly IVDU [78.5%]). Of actual donors with IRB, 393 were seronegative for viral markers at time of donation. A history of recent IVDU was associated with fewer potential donors proceeding to become actual organ donors (64% vs 75%, P = 0.007). Donors with IRB provided 1091 organs for transplantation (624 kidneys and 467 other organs). Transplant outcome was similar in recipients of organs from donors with and without IRB. There were 3 cases of unexpected hepatitis C virus transmission, all from an active IVDU donor who was hepatitis C virus seronegative at time of donation, but was found to be viremic on retrospective testing. CONCLUSIONS: Donors with a history of IRB provide a valuable source of organs for transplantation with good transplant outcomes and there is scope for increasing the use of organs from such donors.
Authors: Courtenay M Holscher; Mary G Bowring; Christine E Haugen; Sheng Zhou; Allan B Massie; Sommer E Gentry; Dorry L Segev; Jacqueline M Garonzik Wang Journal: Transplantation Date: 2019-10 Impact factor: 4.939
Authors: Oliver D Tavabie; Ankur Srivastava; Audrey Dillon; Darius Mirza; Steven Masson; Philip J Smith Journal: Frontline Gastroenterol Date: 2021-06-21
Authors: Patrick B Trotter; Ina Jochmans; William Hulme; Matthew Robb; Christopher Watson; James Neuberger; J Andrew Bradley Journal: Am J Transplant Date: 2018-07-30 Impact factor: 8.086
Authors: Darren Lee; Indra Gramnea; Nina Seng; Meaghan Bruns; Fiona Hudson; Rohit D'Costa; Leanne McEvoy; Joe Sasadeusz; Michael J O'Leary; Gopal Basu; Joshua Y Kausman; Rosemary Masterson; Kathy Paizis; John Kanellis; Peter D Hughes; David J Goodman; John B Whitlam Journal: Transplant Direct Date: 2021-09-07